|
Bingeff |
 |
- First selective EGFR Inhibitor having potential to kill the malignant cell.
- Cease the proliferation of cancerous cancer.
- A credible cure for the treatment of non small cell lung cancer.
Indications |
Gefitinib used for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have previously received chemotherapy.
Gefitinib is also used in the radiation therapy, as radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining gefitinib and radiation therapy with cisplatin may kill more tumor cells. |
| COMPOSITION |
| One strip contains of Bingeff contains Ten Tablets of Gefitinib 250mg |
|
|
|